Retrospective Evaluation of Clinical Factors Associated With Improved Prognosis Of Unresectable Hepatocellular Carcinoma Treated with Lenvatinib Squential Therapy
Latest Information Update: 09 Jul 2020
At a glance
- Drugs Lenvatinib (Primary) ; Regorafenib; Sorafenib
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020
- 06 Dec 2019 New trial record